Chadrick Denlinger to Survival Analysis
This is a "connection" page, showing publications Chadrick Denlinger has written about Survival Analysis.
Connection Strength
0.061
-
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan; 75(1):17-23.
Score: 0.026
-
Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010 Aug; 140(2):377-86.
Score: 0.019
-
Stage IB nonsmall cell lung cancers: are they all the same? Ann Thorac Surg. 2006 Jun; 81(6):1958-62; discussion 1962.
Score: 0.015